Authors:
Bingham, S
Davey, PT
Babbs, AJ
Irving, EA
Sammons, MJ
Wyles, M
Jeffrey, P
Cutler, L
Riba, I
Johns, A
Porter, RA
Upton, N
Hunter, AJ
Parsons, AA
Citation: S. Bingham et al., Orexin-A, an hypothalamic peptide with analgesic properties, PAIN, 92(1-2), 2001, pp. 81-90
Authors:
Barone, FC
Irving, EA
Ray, AM
Lee, JC
Kassis, S
Kumar, S
Badger, AM
Legos, JJ
Erhardt, JA
Ohlstein, EH
Hunter, AJ
Harrison, DC
Philpott, K
Smith, BR
Adams, JL
Parsons, AA
Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145
Authors:
Barone, FC
Irving, EA
May, AM
Lee, JC
Kassis, S
Kumar, S
Badger, AM
White, RF
McVey, MJ
Legos, JJ
Erhardt, JA
Nelson, AH
Ohlstein, EH
Hunter, AJ
Ward, K
Smith, BR
Adams, JL
Parsons, AA
Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321
Citation: Ea. Irving et al., Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat, ACT NEUROP, 102(6), 2001, pp. 627-635
Authors:
Irving, EA
Hadingham, SJ
Roberts, J
Gibbons, M
Chabot-Fletcher, M
Roshak, A
Parsons, AA
Citation: Ea. Irving et al., Decreased nuclear factor-kappa B DNA binding activity following permanent focal cerebral ischaemia in the rat, NEUROSCI L, 288(1), 2000, pp. 45-48
Authors:
Irving, EA
Barone, FC
Reith, AD
Hadingham, SJ
Parsons, AA
Citation: Ea. Irving et al., Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat, MOL BRAIN R, 77(1), 2000, pp. 65-75